68Ga-DOTATATE PET/CT在心脏结节病检测与疗效评估中的潜在临床价值
前瞻性纳入11例心脏结节病患者,对比68Ga-DOTATATE PET/CT与18F-FDG PET/CT。患者水平一致率91%,节段水平一致率77.1%(Kappa 0.53±0.07)。68Ga-DOTATATE的SUVmax与血池比值较低(3.2±0.6 vs 4.9±1.5,P=0.006),且低估治疗反应。
要点
- 68Ga-DOTATATE PET/CT识别活动性心脏结节病的患者水平一致率为91%。
- 节段水平一致率为77.1%,Kappa 0.53±0.07,为中等一致。
- 68Ga-DOTATATE的SUVmax与血池比值低于18F-FDG(3.2±0.6 vs 4.9±1.5,P=0.006)。
核心结论
- 与18F-FDG PET/CT相比,68Ga-DOTATATE PET/CT能以高患者水平一致率识别活动性心脏结节病,但节段水平一致率中等、信号本底比低,且低估治疗反应。
研究设计与样本
- 前瞻性纳入11例心脏结节病患者,均行18F-FDG PET/CT后行心脏68Ga-DOTATATE PET/CT,两种检查独立判读。
- 对8例患者进行了随访68Ga-DOTATATE PET/CT。
主要发现
- 患者水平一致率为91%:10例患者显示多灶性DOTATATE摄取(活动性心脏结节病),1例显示弥漫性DOTATATE摄取。
- 节段水平一致率为77.1%(Kappa 0.53±0.07)。
- 68Ga-DOTATATE PET/CT的SUVmax与血池比值较低(3.2±0.6 vs 4.9±1.5,P=0.006,配对t检验)。
- 随访68Ga-DOTATATE PET/CT显示1例完全缓解、1例部分缓解;18F-FDG PET/CT显示4例缓解,其中3例完全缓解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Somatostatin receptor is expressed in sarcoid granulomas, and preliminary clinical studies have shown that myocardial sarcoidosis can be identified on somatostatin receptor-targeted PET. We examined the potential clinical use of 68Ga-DOTATATE PET/CT for diagnosis and response assessment in cardiac sarcoidosis compared to 18F-FDG PET/CT. METHODS: Eleven cardiac sarcoidosis patients with 18F-FDG PET/CT were prospectively enrolled for cardiac 68Ga-DOTATATE PET/CT. The two PET/CT studies were interpreted independently and were compared for patient-level and segment-level concordance, as well as for the degree of radiotracer uptake. Follow-up 68Ga-DOTATATE PET/CT was performed in eight patients. RESULTS: Patient-level concordance was 91%: ten patients had multifocal DOTATATE uptake (active cardiac sarcoidosis) and one patient showed diffuse DOTATATE uptake. Segment-level agreement was 77.1% (Kappa 0.53 ± 0.07). The SUVmax-to-blood pool ratio was lower on 68Ga-DOTATATE PET/CT (3.2 ± 0.6 vs. 4.9 ± 1.5, P = 0.006 on paired t test). Follow-up 68Ga-DOTATATE PET/CT showed one case of complete response and one case of partial response, while 18F-FDG PET/CT showed four cases of response, including three with complete response. CONCLUSION: Compared to 18F-FDG PET/CT, 68Ga-DOTATATE PET/CT can identify active cardiac sarcoidosis with high patient-level concordance, but with moderate segment-level concordance, low signal-to-background ratio, and underestimation of treatment response.
引用
- Lee H, Schubert EK, Vidula MK, et al. Potential clinical utility of 68Ga-DOTATATE PET/CT for detection and response assessment in cardiac sarcoidosis. J Nucl Cardiol. 2022. PMID: 36266526. doi:10.1007/s12350-022-03111-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。